Drugs / QA108 granules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05562219 | Jun 2022 → Jun 2024 | age-related macular degeneration | Smilebiotek Zhuhai Limited | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | QA108 granules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05562219 ↗ |